Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Proposes PMAs For Pelvic Organ Prolapse Mesh Devices

This article was originally published in The Gray Sheet

Executive Summary

FDA is proposing class III, PMA status for surgical mesh used to treat pelvic organ prolapse based on evidence of health risks including mesh exposures and extrusions, pelvic pain, infections and repeat surgery for complications.


Related Content

PMA Mandate Set For Pelvic Organ Prolapse Transvaginal Mesh
FDA Advisors Call For New Cleaning Methods, Sterilization For Duodenoscopes
Boston Scientific Will Settle Some Transvaginal Surgical Mesh Suits For $119 Mil.
J&J/Ethicon Begins Worldwide Withdrawal Of Vaginal Mesh Products
Surgical Mesh And Sling Devices Must Undergo Post-Market Studies
FDA Panel: Transvaginal Mesh For Prolapse Should Be Class III
Transvaginal Mesh Devices Reassessed: FDA Panel Set For September


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts